Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

and strategic milestones. As Niagen Bioscience, the global leader in NAD+ science and commerce, we have the opportunity to help every living being around the world age better.” Building on a 25+ year legacy, Niagen Bioscience’s renewed mission is...

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

this class1. This prolonged retention of the drug in tumors without proportionate increases to retention in normal tissues helps to explain the positive radiation dosimetry data. Following recent consultation with regulatory authorities, and...

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

WHAT IS CONTRAVE? Along with diet and exercise, CONTRAVE is a prescription weight-loss medicine that may help some adults with a BMI > 30 kg/m2 (obese) or with a BMI of > 27 kg/m2 (overweight) with at least one weight-related medical problem such...

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

access pathways through its AI-driven workflow platform. By streamlining Expanded Access and IIS workflows, MedaSystems helps pharmaceutical companies and healthcare providers efficiently manage requests, improve patient access, and capture...

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

partners in the U.S. IMKELDI’s advanced liquid formulation of imatinib is designed to provide dosing accuracy and can help slow or prevent the growth of specific cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia,...

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

for acute pain, we look forward to advancing the clinical program for LTG-001." Fast Track designation is designed to help drugs reach patients faster by facilitating the development and expediting the review of drugs with the potential to fill an...

Dr. Scott Grady Makes Thyroid RFA More Accessible in Oregon

(RFA) more accessible to Oregon patients seeking a non-surgical alternative for benign thyroid nodules. Since 2022, he has helped patients avoid surgery while effectively shrinking nodules and preserving thyroid function. Thyroid RFA offers a...

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

basic scientific discovery. Through custom products and services, including recombinant antibody engineering services, we help fuel our customers’ development of next-generation therapeutics. Vector Laboratories is building on 45+ years of...

LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region

multi-year agreement solidifies the partnership, and enables both organizations to leverage complementary strengths to help get patients the medicines they need by meeting the growing regional demand of clinical trial support services for...

Regemat 3D to Distribute VitroInk® Bioinks in Europe: A Strategic Move for Advanced Bioprinting Solutions

of VitroGel®, an animal-free synthetic biofunctional hydrogel, enables scientists to shift from 2D to 3D cell culture and help drive innovations for precision medicine, cell therapy, and biomanufacturing by getting faster and more accurate data...

A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate

soon be initiating a pilot sickle cell clinical trial evaluating both topical and sublingual routes of administration. To help us speed the progression of VAS-101 into an eventual FDA-approved therapy, we welcome discussions with other...

PointClickCare Integration Announced by AccessDx Laboratory

drug-gene interactions for their residents. "We're pleased to announce our integration into PointClickCare's solution that helps to enable both access and efficient use of precision medicine solutions that benefit LTPAC providers and residents...

Fosun Pharma deeply embraces AI, with its self-developed PharmAID Decision Intelligence Platform boosting efficient innovation

imaging products can quickly and accurately analyze medical imaging data, providing doctors with diagnostic suggestions, helping them more efficiently identify lesions and assess conditions, thereby improving diagnostic accuracy and timeliness. The...

Fresenius Kabi Launches Calcitonin Salmon Injection, USP Synthetic

supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a...

Marius Pharmaceuticals Expands Men's Health Solutions by Announcing the Availability of KYZATREX® (testosterone undecanoate) CIII Capsules Through Thrive

convenient treatment options,” said Amit Shah, COO of Marius Pharmaceuticals. “By expanding access to oral TRT, we are helping more men take control of their health in a way that fits seamlessly into their lifestyles." About Marius Pharmaceuticals:...

New FDA-Cleared Treatment for Fibromyalgia Symptoms from Swing Therapeutics Covered by Highmark

as behavioral care, sleep management, meaningful movement coaching, and peer support. “At Swing Care, we’re committed to helping patients find real relief with a supportive, comprehensive approach to managing fibromyalgia that truly improves...

Jabil acquires Pharmaceutics International, Inc

February 3, 2025. “As the pace of healthcare innovation accelerates, pharmaceutical companies need partners who can help them scale rapidly with a focus on quality and safety. Jabil and Pii’s combined capabilities can provide end-to-end support for...

Dipal Doshi has been elected to Azenta's Board of Directors

commitment to growth and innovation is clear. I look forward to collaborating with the Board and the leadership team to help shape the company's future and make a meaningful impact." About Dipal Doshi: Mr. Doshi is the CEO of Entrada Therapeutics...

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

solutions. By leveraging our expertise in generating both qualitative and quantitative insights, we are committed to helping businesses stay ahead in an ever-evolving industry," said Sahil Singla, Director of PharmaScroll. PharmaScroll's...

Lutris Pharma secures $30 million in financing to advance the development of a biopharmaceutical aimed at improving the effectiveness of anti-cancer drugs

wherein EGFRi treatment will be regularly coupled with LUT014 as a valuable adjunct. This aligns with aMoon's mission of helping people live longer, healthier lives, and we are proud to support Lutris on their journey towards success." About EGFR...